The Limited Times

Now you can see non-English news...

Covid-19: Europe awaits EMA verdict on Johnson & Johnson vaccine


The European Medicines Agency is organizing a press conference on Tuesday to deliver its verdict on the use of this single-dose vaccine.

The European Medicines Agency (EMA) issues its opinion this Tuesday on the Johnson & Johnson vaccine against Covid-19, the use of which is suspended in the United States and Europe due to the rare occurrence of serious blood clots .

The EMA, which has its headquarters in Amsterdam, must give Tuesday, a priori at 16:00, a "

virtual press conference on the conclusions about the safety assessment

" of this single-dose vaccine.

This decision is all the more important as several European countries, including France, are counting on this vaccine to speed up their immunization campaign.

Read also: Covid-19: Europe bets on vaccines to counter variants

The uncertainty on the viability of the vaccine remains unresolved, while the US health authorities last Tuesday recommended "

a pause

" in the use of Johnson & Johnson to investigate the occurrence of serious cases of blood clots in several people in the USA. However, its use should be re-authorized, perhaps accompanied by "


", and a decision should be made public by Friday, White House medical adviser Anthony Fauci said on Sunday. “

I think (vaccination) will resume, maybe with restrictions. I'm not sure what it will be, if it will be related to age or gender, or if it will just be accompanied by a warning

”,he asserted.

Source: lefigaro

All business articles on 2021-04-20

You may like

News/Politics 2021-04-21T03:06:23.347Z
News/Politics 2021-04-15T08:28:48.639Z

Trends 24h


© Communities 2019 - Privacy